These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9777110)

  • 1. NSAIDs and faecal blood loss in elderly patients with osteoarthritis: is plasma half-life relevant?
    Scharf S; Kwiatek R; Ugoni A; Christophidis N
    Aust N Z J Med; 1998 Aug; 28(4):436-9. PubMed ID: 9777110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
    Melo Gomes JA; Roth SH; Zeeh J; Bruyn GA; Woods EM; Geis GS
    Ann Rheum Dis; 1993 Dec; 52(12):881-5. PubMed ID: 8311540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.
    Laine L; Curtis SP; Langman M; Jensen DM; Cryer B; Kaur A; Cannon CP
    Gastroenterology; 2008 Nov; 135(5):1517-25. PubMed ID: 18823986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Lister BJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole.
    Andersson T; Bredberg E; Lagerström PO; Naesdal J; Wilson I
    Eur J Clin Pharmacol; 1998 Jul; 54(5):399-404. PubMed ID: 9754983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Eversmeyer W; Poland M; DeLapp RE; Jensen CP
    Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
    Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
    JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
    Karim A; Noveck R; McMahon FG; Smith M; Crosby S; Adams M; Wilton J
    J Clin Pharmacol; 1997 Apr; 37(4):267-78. PubMed ID: 9115051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.
    Watson M; Brookes ST; Faulkner A; Kirwan J
    Cochrane Database Syst Rev; 2007 Jul; 2006(1):CD000142. PubMed ID: 17636601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam.
    Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ
    Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers.
    van Hecken A; Depré M; Wynants K; Vanbilloen H; Verbruggen A; Arnout J; Vanhove P; Cariou R; De Schepper PJ
    Drug Metabol Drug Interact; 1998; 14(3):193-205. PubMed ID: 10366994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and upper GI safety of diclofenac/misoprostol, piroxicam and naproxen in patients with osteoarthritis.
    Geis GS
    Drugs; 1993; 45 Suppl 1():15; discussion 15-6, 36-7. PubMed ID: 7685683
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Platt PN
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():54-62. PubMed ID: 2525984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety.
    Scott DL; Palmer RH
    Aliment Pharmacol Ther; 2000 Apr; 14(4):443-52. PubMed ID: 10759624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding.
    Massó González EL; Patrignani P; Tacconelli S; García Rodríguez LA
    Arthritis Rheum; 2010 Jun; 62(6):1592-601. PubMed ID: 20178131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
    Morgan GJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding?
    Wynne HA; Long A; Nicholson E; Ward A; Keir D
    Br J Clin Pharmacol; 1998 Apr; 45(4):405-8. PubMed ID: 9578191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.